Global Natural Killer (NK) Cell Therapeutics Market Insights, Research, Forecast to 2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 116

Report ID: 348247

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.
The global Natural Killer (NK) Cell Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Natural Killer (NK) Cell Therapeutics market based on company, product type, end user and key regions.

This report studies the global market size of Natural Killer (NK) Cell Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Natural Killer (NK) Cell Therapeutics in these regions.
This research report categorizes the global Natural Killer (NK) Cell Therapeutics market by top players/brands, region, type and end user. This report also studies the global Natural Killer (NK) Cell Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)

Market size by Product
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market size by End User
Cancer
Cardiovascular Diseases
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Natural Killer (NK) Cell Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Natural Killer (NK) Cell Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Natural Killer (NK) Cell Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Natural Killer (NK) Cell Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Natural Killer (NK) Cell Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Natural Killer (NK) Cell Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Natural Killer (NK) Cell Therapeutics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Product
1.4.2 Mogamulizumab
1.4.3 Lorvotuzumab Mertansine
1.4.4 Others
1.5 Market by End User
1.5.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by End User
1.5.2 Cancer
1.5.3 Cardiovascular Diseases
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Natural Killer (NK) Cell Therapeutics Market Size
2.1.1 Global Natural Killer (NK) Cell Therapeutics Revenue 2014-2025
2.1.2 Global Natural Killer (NK) Cell Therapeutics Sales 2014-2025
2.2 Natural Killer (NK) Cell Therapeutics Growth Rate by Regions
2.2.1 Global Natural Killer (NK) Cell Therapeutics Sales by Regions
2.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Natural Killer (NK) Cell Therapeutics Sales by Manufacturers
3.1.1 Natural Killer (NK) Cell Therapeutics Sales by Manufacturers
3.1.2 Natural Killer (NK) Cell Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Natural Killer (NK) Cell Therapeutics Revenue by Manufacturers
3.2.1 Natural Killer (NK) Cell Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Natural Killer (NK) Cell Therapeutics Revenue Share by Manufacturers (2014-2019)
3.3 Natural Killer (NK) Cell Therapeutics Price by Manufacturers
3.4 Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Natural Killer (NK) Cell Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Natural Killer (NK) Cell Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Natural Killer (NK) Cell Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Natural Killer (NK) Cell Therapeutics Sales by Product
4.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Product
4.3 Natural Killer (NK) Cell Therapeutics Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Natural Killer (NK) Cell Therapeutics Breakdown Data by End User

6 North America
6.1 North America Natural Killer (NK) Cell Therapeutics by Countries
6.1.1 North America Natural Killer (NK) Cell Therapeutics Sales by Countries
6.1.2 North America Natural Killer (NK) Cell Therapeutics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Natural Killer (NK) Cell Therapeutics by Product
6.3 North America Natural Killer (NK) Cell Therapeutics by End User

7 Europe
7.1 Europe Natural Killer (NK) Cell Therapeutics by Countries
7.1.1 Europe Natural Killer (NK) Cell Therapeutics Sales by Countries
7.1.2 Europe Natural Killer (NK) Cell Therapeutics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Natural Killer (NK) Cell Therapeutics by Product
7.3 Europe Natural Killer (NK) Cell Therapeutics by End User

8 Asia Pacific
8.1 Asia Pacific Natural Killer (NK) Cell Therapeutics by Countries
8.1.1 Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Countries
8.1.2 Asia Pacific Natural Killer (NK) Cell Therapeutics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Natural Killer (NK) Cell Therapeutics by Product
8.3 Asia Pacific Natural Killer (NK) Cell Therapeutics by End User

9 Central & South America
9.1 Central & South America Natural Killer (NK) Cell Therapeutics by Countries
9.1.1 Central & South America Natural Killer (NK) Cell Therapeutics Sales by Countries
9.1.2 Central & South America Natural Killer (NK) Cell Therapeutics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Natural Killer (NK) Cell Therapeutics by Product
9.3 Central & South America Natural Killer (NK) Cell Therapeutics by End User

10 Middle East and Africa
10.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics by Countries
10.1.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Countries
10.1.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics by Product
10.3 Middle East and Africa Natural Killer (NK) Cell Therapeutics by End User

11 Company Profiles
11.1 Chipscreen Biosciences (China)
11.1.1 Chipscreen Biosciences (China) Company Details
11.1.2 Company Business Overview
11.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Products Offered
11.1.5 Chipscreen Biosciences (China) Recent Development
11.2 Affimed NV (Netherlands)
11.2.1 Affimed NV (Netherlands) Company Details
11.2.2 Company Business Overview
11.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Products Offered
11.2.5 Affimed NV (Netherlands) Recent Development
11.3 Altor BioScience Corporation (USA)
11.3.1 Altor BioScience Corporation (USA) Company Details
11.3.2 Company Business Overview
11.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Products Offered
11.3.5 Altor BioScience Corporation (USA) Recent Development
11.4 Innate Pharma SA (France)
11.4.1 Innate Pharma SA (France) Company Details
11.4.2 Company Business Overview
11.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Products Offered
11.4.5 Innate Pharma SA (France) Recent Development
11.5 Takeda Pharmaceutical (Japan)
11.5.1 Takeda Pharmaceutical (Japan) Company Details
11.5.2 Company Business Overview
11.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Products Offered
11.5.5 Takeda Pharmaceutical (Japan) Recent Development
11.6 Sorrento Therapeutics Inc. (USA)
11.6.1 Sorrento Therapeutics Inc. (USA) Company Details
11.6.2 Company Business Overview
11.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Products Offered
11.6.5 Sorrento Therapeutics Inc. (USA) Recent Development
11.7 NantKwest Inc. (USA)
11.7.1 NantKwest Inc. (USA) Company Details
11.7.2 Company Business Overview
11.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Products Offered
11.7.5 NantKwest Inc. (USA) Recent Development
11.8 Bristol-Myers Squibb (USA)
11.8.1 Bristol-Myers Squibb (USA) Company Details
11.8.2 Company Business Overview
11.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Products Offered
11.8.5 Bristol-Myers Squibb (USA) Recent Development
11.9 NKT Therapeutics (USA)
11.9.1 NKT Therapeutics (USA) Company Details
11.9.2 Company Business Overview
11.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Products Offered
11.9.5 NKT Therapeutics (USA) Recent Development

12 Future Forecast
12.1 Natural Killer (NK) Cell Therapeutics Market Forecast by Regions
12.1.1 Global Natural Killer (NK) Cell Therapeutics Sales Forecast by Regions 2019-2025
12.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Regions 2019-2025
12.2 Natural Killer (NK) Cell Therapeutics Market Forecast by Product
12.2.1 Global Natural Killer (NK) Cell Therapeutics Sales Forecast by Product 2019-2025
12.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Product 2019-2025
12.3 Natural Killer (NK) Cell Therapeutics Market Forecast by End User
12.4 North America Natural Killer (NK) Cell Therapeutics Forecast
12.5 Europe Natural Killer (NK) Cell Therapeutics Forecast
12.6 Asia Pacific Natural Killer (NK) Cell Therapeutics Forecast
12.7 Central & South America Natural Killer (NK) Cell Therapeutics Forecast
12.8 Middle East and Africa Natural Killer (NK) Cell Therapeutics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Natural Killer (NK) Cell Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer